Novo Nordisk is trading 6.2% down now at $40.58 (-6.15%) as investors seek clearer plans to restore growth beyond Wegovy and compete with Eli Lilly. • Manageme

Novo Nordisk is trading 6.2% down now at $40.58 (-6.15%) as investors seek clearer plans to restore growth beyond Wegovy and compete with Eli Lilly. • Management will present strategy, pipeline, operations, and performance updates in London at its September 21, 2026 Capital Markets Day. • The broad…